Rheumatoid arthritis (RA), primarily a chronic inflammatory debilitating autoimmune disease of the synovial joint linings has prevalence of about 0.5% in the population world over. Role of serum vitamin (vit-D) (25hydroxyvitamin D (25(OH)D) has been found quite potential and promising for preventing certain manifestations in general population. Serum vit-D (ng/ml) was measured by ELISA technique for assessing its association with age (years) and duration of disease (DD) in male patients (n: 71, age 55-59 years, DD: 115 years) with RA (subgroups: RA-DD 1-5 years, RA-DD 6-10 years, RA-DD 11-15 years. Healthy male subjects served as controls (n: 40, age: 55-59) for comparing the vitamin D levels in male patients with RA. Highly significant decrease in vit-D was found in the RA patients with DD of 6-10 and 11-15 years (P<0.0001). In general, the RA patients with DD of 1-15 showed a highly significant decrease in vit-D levels. The DD 1-5 vs. DD 6-10 and DD 1-5 vs. DD 11-15 gave significant variations. Age against vit-D gave highly significant correlation for control subjects (R2: 0.554, P <0.0001). Patients with RA-DD 1-15 years showed highly significant correlation (R2: 0.408, P <0.0001) for the DD and vit-D. Subgroups of RA did not show significant correlations due to lowered levels of vit-D except RA-DD 11-15 that showed significant correlation (R2: 0.223, P:0.015). Conclusively, the interventional approaches to supplement vit-D for improving the serum levels of vit-D in patients with RA of better controlled larger sample size seem potentially beneficial for future studies.